Macrogenics (MGNX) Other Working Capital Changes (2018 - 2026)
Macrogenics (MGNX) posted quarterly Other Working Capital Changes of -$324000.0 for Q1 2026, down 6580.0% year-over-year from $5000.0 in Q1 2025, and down 214.89% quarter-over-quarter from $282000.0 in Q4 2025.
Analysis
Macrogenics (MGNX) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Macrogenics (MGNX) has reported Other Working Capital Changes for 9 consecutive years, with -$324000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 6580.0% year-over-year to -$324000.0; the TTM figure through Mar 2026 stood at -$5.7 million (up 23.98% YoY), while the FY2025 annual figure was -$5.4 million, up 42.66% from the prior year.
- Other Working Capital Changes slipped to -$324000.0 in Q1 2026 per MGNX's latest filing, from $282000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $14.0 million in Q4 2022 and bottomed at -$6.5 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged $989142.9 across 5 years, with a median of -$70500.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 1751.54% — and 2026, when it plunged 6580.0%.
- Macrogenics' Other Working Capital Changes stood at $57.3 million in 2022, then plunged by 78.8% to $12.1 million in 2023, then tumbled by 178.54% to -$9.5 million in 2024, then soared by 102.96% to $282000.0 in 2025, then sank by 214.89% to -$324000.0 in 2026.
- Business Quant data shows MGNX's Other Working Capital Changes at -$324000.0 in Q1 2026, $282000.0 in Q4 2025, and -$5.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Macrogenics | 284.90 Mn | 171.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.30 Mn |
| Jun 30, 2026 | -4.30 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | 282,000.00 |
| Dec 31, 2025 | 282,000.00 |
| Sep 30, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Mar 31, 2025 | -264,000.00 |
| Mar 31, 2025 | -264,000.00 |
| Dec 31, 2024 | -7.33 Mn |
| Dec 31, 2024 | -7.33 Mn |
| Sep 30, 2024 | -511,000.00 |
| Sep 30, 2024 | -511,000.00 |
| Jun 30, 2024 | 302,000.00 |
| Jun 30, 2024 | 302,000.00 |
| Mar 31, 2024 | -1.88 Mn |
| Mar 31, 2024 | -1.88 Mn |